SEARCH

SEARCH BY CITATION

References

  • Beech, J., Boston, R.C., McFarlane, D. and Lindborg, S. (2009) Evaluation of plasma ACTH, α-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction. J. Am. vet. med. Ass. 235, 715-722.
  • Couetil, L., Paradis, M.R. and Knoll, J. (1996) Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J. vet. intern. Med. 10, 1-6.
  • Donaldson, M.T., Jorgensen, A.J.R. and Beech, J. (2004) Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J. Am. vet. med. Ass. 224, 1123-1127.
  • Donaldson, M.T., McDonnell, S.M., Schanbacher, B.J., Lamb, S.V., Mcfarlane, D. and Beech, J. (2005) Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J. vet. intern. Med. 19, 217-222.
  • Dybdal, N.O., Hargreaves, K.M., Madigan, J.E., Gribble, D.H., Kennedy, P.C. and Stabenfeldt, G.H. (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J. Am. vet. med. Ass. 204, 627-632.
  • Frank, N., Elliott, S.B., Chameroy, F., Toth, F., Chumbler, N.S. and McClamroch, R. (2010) Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction. J. vet. intern. Med. 24, 1167-1175.
  • Geffre, A., Friedrichs, K., Harr, K., Concordet, D., Trumel, C. and Braun, J.-P. (2009) Reference values: a review. Vet. clin. Pathol. 38, 288-298.
  • Horn, P.S. and Pesce, A.J. (2003) Reference intervals: an update. Clin. Chim. Acta 334, 5-23.
  • Horn, P.S., Pesce, A.J. and Copeland, B.E. (1998) A robust approach to reference interval estimation and evaluation. Clin. Chem. 44, 622-631.
  • Horowitz, G.L., Altaie, S., Boyd, J.C., Ceriotti, F., Garg, U., Horn, P., Pesce, A., Sine, H.E. and Zakowski, J. (2008) Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory . Approved Guideline, 3rd edn. Clinical and Laboratory Standards Institute. http://www.clsi.org (accessed 10/12/2010).
  • Lee, Z.Y., Zylstra, R. and Haritou, S.J.A. (2010) The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses. Vet. J. 185, 58-61.
  • McFarlane, D., Dybdal, N., Donaldson, M.T., Miller, L. and Cribb, A.E. (2005a) Nitration and increased α-Synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J. Neuroendocrinol. 17, 73-80.
  • McFarlane, D., Miller, L.M., Craig, L.E., Dybdal, N.O., Habecker, P.O., Miller, M.A., Patterson, J.S. and Cribb, A.E. (2005b) Agreement in histologic assessments of the pituitary pars intermedia in aged horses. Am. J. vet. Res. 66, 2055-2059.
  • McGowan, T.W., Hodgson, D.R. and McGowan, C.M. (2007) The prevalence of equine Cushing's syndrome in aged horses. JVIM 21, 603.
  • Miesner, T.J., Beard, L.A., Schmall, S.M. and Reed, S.M. (2003) Results of overnight dexamethasone suppression test repeated over time in horses suspected of having equine Cushing's disease. JVIM 17, 420.
  • Perkins, G.A., Lamb, S., Erb, H.N., Schanbacher, B., Nydam, D.V. and Divers, T.J. (2002) Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine vet. J. 34, 679-685.
  • Place, N.J., McGowan, C.M., Lamb, S.V., Schanbacher, B.J., McGowan, T.W. and Walsh, D.M. (2010) Seasonal variation in serum concentrations of selected metabolic hormones in horses. J. vet. intern. Med. 24, 650-654.
  • Schott, H.C. (2002) Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet. Clin. N. Am.: Equine Pract. 18, 237-270.
  • Schott, H.C., Eberhart, S.W., Nachreiner, R.F. and Beyerlein, S. (2007) Effect of season on overnight dexamethasone suppression test results in aged horses without clinical signs of pituitary pars intermedia dysfunction. Vet. Dermatol. 18, 193.
  • Toribio, R.E. (2005) Editorial: Diagnosing equine pars intermedia dysfunction: are we there yet? J. vet. intern. Med. 19, 145-146.
  • Towns, T.J., Stewart, A.J., Hackett, E., Zhong, Q., Munsterman, A., Wooldridge, A.A., Funk, R.A. and Hewes, C.A. (2010) Cortisol and ACTH concentrations in ill horses throughout 6 days of hospitalisation. Proc. IVECCS 16, A16.
  • Van der Kolk, J.H., Wensing, T., Kalsbeek, H.C. and Breukink, H.J. (1995) Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest. Anim. Endocrinol. 12, 35-39.